Electrical stimulation to relieve chemotherapy-related nerve pain in breast cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcutaneous electrical acupoint stimulation on alleviating symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. It will recruit 86 patients who have recently completed chemotherapy and are experiencing nerve-related symptoms. Participants will be randomly assigned to either the stimulation group, receiving the intervention for four weeks, or a control group with no treatment. Data will be collected at multiple time points to assess the effectiveness of the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Primary diagnosed with breast cancer for the first time by a physician.
2. Patients who have completed chemotherapy or postoperative adjuvant chemotherapy within 3 months, and the chemotherapy drugs used are paclitaxel, vinblastine or platinum drugs.
3. Patients who have been evaluated by doctors as peripheral neuropathy caused by chemotherapy, and whose symptoms persist after completing chemotherapy.
4. Peripheral sensory or peripheral motor neuropathy grade ≥ 2 in general toxicity criteria (NCI-CTCAE).
5. Those who have clear consciousness and can communicate in Mandarin or Taiwanese.

Exclusion Criteria:

1. Patients suffering from carcinoma in situ.
2. Patients suffering from stage IV cancer.
3. Patients suffering from metastatic cancer.
4. Patients receiving peripheral neuropathy drugs (Duloxetine)
5. Patients receiving acupoint stimulation therapy.
6. Patients who are allergic to silicone patches.
7. Patients with cardiac pacemakers.
8. Patients suffering from diabetic peripheral neuropathy.
9. Patients suffering from peripheral neuropathy of acquired immunodeficiency syndrome.
10. Patients receiving treatment for mental illness.

Where it's running

• Changhua Christian Hospital
  Changhua, Changhua, Taiwan Recruiting

Study contacts

• Principal investigator: Wang, Phd — National Taipei University of Nursing and Health Sciences
• Study coordinator: Chia Hao Yang
• Email: henry1993110101@gmail.com
• Phone: +886912631133

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors

  This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.

  Recruiting Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Murcia, Murcia · NCT07917117

• Breast cancer subtypes and outcomes in Colombian women

  This study looks back at medical records of women with breast cancer to see how different molecular subtypes relate to survival and recurrence in a single Colombian hospital.

  Recruiting Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. · NCT07856225

• Cryotherapy during weekly paclitaxel to reduce chemotherapy-induced numbness and tingling

  This study tests whether applying cryotherapy to hands and feet during weekly paclitaxel helps prevent CIPN in women with breast cancer.

  Recruiting at 3 sites Azienda Sanitaria dell'Alto Adige · Bolzano, Bolzano and 3 other locations · NCT07780955

• SIR2501 plus Paclitaxel for solid tumors

  This Phase 2 study tests SIR2501 in adults with solid tumors who are starting paclitaxel chemotherapy to see if it is safe and tolerable and to explore its effect on chemotherapy-induced neuropathy.

  Recruiting at 3 sites Phase 2 Sironax USA, Inc. · Hollywood, Florida and 4 other locations · NCT07765446

• Multimodal psychosomatic symptom care for breast cancer: personalized acupuncture care guided by shared decision-making

  This study tests whether personalized acupuncture options (manual acupuncture, ear acupuncture, or both) can help women with breast cancer who have anxiety, sleep problems, or fatigue, compared to routine nursing care.

  Recruiting at 3 sites First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Tianjin and 2 other locations · NCT07763587

• Slow Jogging for Breast Cancer Survivors

  This study tests whether a 12-week slow jogging program helps sleep quality in women who have completed breast cancer treatment.

  Recruiting Mackay Memorial Hospital · Taipei, Taipei City · NCT07757763

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.